生物材料
纳米技术
生物相容性材料
组织工程
材料科学
生化工程
生物医学工程
工程类
作者
Hui Xu,Yan Su,Ethan Gerhard,Denghui Xie,Xiaodong Liu,Bing Zhang,Dongquan Shi,Guillermo A. Ameer,Jian Yang
标识
DOI:10.1002/adma.202402871
摘要
Abstract Citrate‐based biodegradable polymers have emerged as a distinctive biomaterial platform with tremendous potential for diverse medical applications. By harnessing their versatile chemistry, these polymers exhibit a wide range of material and bioactive properties, enabling them to regulate cell metabolism and stem cell differentiation through energy metabolism, metabonegenesis, angiogenesis, and immunomodulation. Moreover, the recent US Food and Drug Administration (FDA) clearance of the biodegradable poly(octamethylene citrate) (POC)/hydroxyapatite‐based orthopedic fixation devices represents a translational research milestone for biomaterial science. POC joins a short list of biodegradable synthetic polymers that have ever been authorized by the FDA for use in humans. The clinical success of POC has sparked enthusiasm and accelerated the development of next‐generation citrate‐based biomaterials. This review presents a comprehensive, forward‐thinking discussion on the pivotal role of citrate chemistry and metabolism in various tissue regeneration and on the development of functional citrate‐based metabotissugenic biomaterials for regenerative engineering applications.
科研通智能强力驱动
Strongly Powered by AbleSci AI